Innate immunity and the role of the antimicrobial peptide cathelicidin in inflammatory skin disease

Drug Discovery Today: Disease Mechanisms

Volumn 10, Issue 3-4, 2013, Pages

  Roby, Keith D ^a   Di Nardo, Anna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN;

ANTIMICROBIAL ACTIVITY; ATOPIC DERMATITIS; DERMATITIS; HUMAN; INNATE IMMUNITY; KERATINOCYTE; NONHUMAN; PSORIASIS; REVIEW; ROSACEA; SKIN INFECTION;

EID: 84886101849     PISSN: None     EISSN: 17406765     Source Type: Journal    
DOI: 10.1016/j.ddmec.2013.01.001     Document Type: Review

References (39)

1. G.H. Gudmundsson Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39 Proc. Natl. Acad. Sci. U. S. A. 92 1995 7085 7089
2. A. Eissa Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade J. Biol. Chem. 286 2011 687 706
3. M.D. Howell Cathelicidin deficiency predisposes to eczema herpeticum J. Allergy Clin. Immunol. 2006 836 841
4. B. Lopez-Garcia Expression and potential function of cathelicidin antimicrobial peptides in dermatophytosis and tinea versicolor J. Antimicrob. Chemother. 57 2006 877 882
5. V. Nizet Innate antimicrobial peptide protects the skin from invasive bacterial infection Nature 414 2001 454 457
6. M. Zaiou Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence J. Invest. Dermatol. 120 2003 810 816
7. Z. Oren Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity Biochem. J. 341 Pt 3 1999 501 513
8. A. Di Nardo Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin J. Immunol. 180 2008 7565 7573
9. M. Frohm The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders J. Biol. Chem. 272 1997 15258 15263
10. M. Murakami Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin J. Invest. Dermatol. 119 2002 1090 1095
11. B. Agerberth The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations Blood 96 2000 3086 3093
12. T.T. Wang Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression J. Immunol. 173 2004 2909 2912
13. B.E. Menzies, and A. Kenoyer Staphylococcus aureus infection of epidermal keratinocytes promotes expression of innate antimicrobial peptides Infect. Immun. 73 2005 5241 5244
14. J. Schauber Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism J. Clin. Invest. 117 2007 803 811
15. Y. De LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells J. Exp. Med. 192 2000 1069 1074
16. F. Niyonsaba A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis Immunology 106 2002 20 26
17. J.D. Heilborn The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium J. Invest. Dermatol. 120 2003 379 389
18. R. Koczulla An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 J. Clin. Invest. 111 2003 1665 1672
19. J. Karlsson Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia Br. J. Haematol. 137 2007 166 169
20. S.M. Travis Bactericidal activity of mammalian cathelicidin-derived peptides Infect. Immun. 68 2000 2748 2755
21. P.W. Tsai Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates PLoS One 6 2011 e17755
22. Z. Wang Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides J. Immunol. 188 2012 345 357
23. V. Nizet, and R.L. Gallo Cathelicidins and innate defense against invasive bacterial infection Scand. J. Infect. Dis. 35 2003 670 676
24. H. Williams Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood J. Allergy Clin. Immunol. 103 Pt 1 1999 125 138
25. M.J. Cork New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions J. Allergy Clin. Immunol. 118 3-21 2006 (quiz 22-23)
26. N. Novak, and D.Y. Leung Advances in atopic dermatitis Curr. Opin. Immunol. 23 6 2011 778 783
27. P.Y. Ong Endogenous antimicrobial peptides and skin infections in atopic dermatitis N. Engl. J. Med. 347 15 2002 1151 1160
28. M.D. Howell Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus Immunity 24 3 2006 341 348
29. M.D. Howell Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis J. Invest. Dermatol. 125 4 2005 738 745
30. J.V. Williams Staphylococcus aureus isolation from the lesions, the hands, and anterior nares of patients with atopic dermatitis J. Emerg. Med. 17 1 1999 207 211
31. K. Vahavihu Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis Br. J. Dermatol. 163 2 2010 321 328
32. T.R. Hata Administration of oral vitamin D induces cathelicidin production in atopic individuals J. Allergy Clin. Immunol. 122 4 2008 829 831
33. R. Lande Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide Nature 449 7162 2007 564 569
34. Y. Zhang Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1 J. Immunol. 188 5 2012 2127 2135
35. J.K. Wilkin Rosacea Int. J. Dermatol. 22 7 1983 393 400
36. K. Yamasaki Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea Nat. Med. 13 8 2007 975 980
37. K. Yamasaki TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes J. Invest. Dermatol. 131 3 2011 688 697
38. E. Monk Clinical applications of non-antimicrobial tetracyclines in dermatology Pharmacol. Res. 63 2 2011 130 145
39. T. Jansen BsmI polymorphism of the vitamin D receptor gene in patients with the fulminant course of rosacea conglobata (rosacea fulminans) J. Dermatol. 31 3 2004 244 246